These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2597224)
21. Calcium antagonists suppress atherogenesis in aorta but not in the intramural coronary arteries of cholesterol-fed rabbits. Ginsburg R; Davis K; Bristow MR; McKennett K; Kodsi SR; Billingham ME; Schroeder JS Lab Invest; 1983 Aug; 49(2):154-8. PubMed ID: 6876744 [TBL] [Abstract][Full Text] [Related]
22. Effect of benidipine on depolarizing stimulation-induced increase of intracellular calcium concentration in cultured mouse hippocampal neurons. Tsukuda E; Matsuda Y Jpn J Pharmacol; 1999 Dec; 81(4):401-3. PubMed ID: 10669048 [TBL] [Abstract][Full Text] [Related]
23. Binding of the new calcium entry blocker nilvadipine to rat aortic and guinea pig left ventricular membranes. Matsuo M; Koibuchi Y; Tomoi M; Ono T; Shibayama F; Ohtsuka M Arzneimittelforschung; 1989 May; 39(5):576-9. PubMed ID: 2757673 [TBL] [Abstract][Full Text] [Related]
24. Nilvadipine, a new calcium channel blocker, reduces ischemic brain injury in rats. Takakura S; Susumu T; Satoh H; Mori J; Shiino A; Handa J Jpn J Pharmacol; 1991 Aug; 56(4):547-50. PubMed ID: 1744995 [TBL] [Abstract][Full Text] [Related]
25. Effect of lomerizine, a new Ca(2+)channel blocker, on the microcirculation in the optic nerve head in conscious rabbits: a study using a laser speckle technique. Shimazawa M; Sugiyama T; Azuma I; Araie M; Iwakura Y; Watari M; Sakai T; Hara H Exp Eye Res; 1999 Aug; 69(2):185-93. PubMed ID: 10433855 [TBL] [Abstract][Full Text] [Related]
26. Erythrocyte sodium cannot predict hypotensive effects of calcium channel blockers. Oshima T; Matsuura H; Ozono R; Ishida-Kainouchi M; Ishida T; Ishibashi K; Watanabe M; Okura Y; Kanbe M; Kajiyama G Nihon Jinzo Gakkai Shi; 1993 Nov; 35(11):1227-31. PubMed ID: 8139134 [TBL] [Abstract][Full Text] [Related]
27. Effects of nilvadipine, nicardipine and verapamil on acute rise of aqueous flare induced by iris photocoagulation or intravenous lipopolysaccharides in pigmented rabbits. Zhang XY; Hiraki S; Kadoi C; Hayasaka S Ophthalmic Res; 2000; 32(5):205-9. PubMed ID: 10971181 [TBL] [Abstract][Full Text] [Related]
28. Study of drug effects of calcium channel blockers on retinal degeneration of rd mouse. Takano Y; Ohguro H; Dezawa M; Ishikawa H; Yamazaki H; Ohguro I; Mamiya K; Metoki T; Ishikawa F; Nakazawa M Biochem Biophys Res Commun; 2004 Jan; 313(4):1015-22. PubMed ID: 14706644 [TBL] [Abstract][Full Text] [Related]
29. Effects of nilvadipine (a dihydropyridine-type calcium entry blocker) on cerebral blood flow in acute experimental brain ischemia in rats. Tanaka R; Miyasaka Y; Maruyama S; Nagai S; Fujii K Neurol Res; 1996 Aug; 18(4):325-8. PubMed ID: 8875450 [TBL] [Abstract][Full Text] [Related]
30. Effects of nilvadipine, a calcium antagonist, on rabbit ocular circulation and optic nerve head circulation in NTG subjects. Tomita K; Araie M; Tamaki Y; Nagahara M; Sugiyama T Invest Ophthalmol Vis Sci; 1999 May; 40(6):1144-51. PubMed ID: 10235547 [TBL] [Abstract][Full Text] [Related]
31. Nilvadipine. A review of its pharmacodynamic and pharmacokinetic properties, therapeutic use in hypertension and potential in cerebrovascular disease and angina. Brogden RN; McTavish D Drugs Aging; 1995 Feb; 6(2):150-71. PubMed ID: 7711361 [TBL] [Abstract][Full Text] [Related]
32. Effects of calcium channel entry blockers, nifedipine and nilvadipine, on colonic motor activity. Barone FC; White RF; Ormsbee HS; Wasserman MA J Pharmacol Exp Ther; 1986 Apr; 237(1):99-106. PubMed ID: 2420971 [TBL] [Abstract][Full Text] [Related]
33. Effect of nilvadipine on balloon catheterization-induced intimal thickening of the coronary artery in miniature pigs. Arakawa H; Mutoh S; Hirosumi J; Yamaguchi I J Cardiovasc Pharmacol; 1992; 20(5):731-4. PubMed ID: 1280734 [TBL] [Abstract][Full Text] [Related]
34. A nifedipine-sensitive smooth muscle cell population is present in the atherosclerotic rabbit aorta. Pauletto P; Scannapieco G; Borrione AC; Zanellato AM; Tonello M; Giuriato L; Pessina AC; Palù CD; Sartore S Arterioscler Thromb; 1991; 11(4):928-39. PubMed ID: 2065044 [TBL] [Abstract][Full Text] [Related]
35. [Biochemical effects of ryodipine (foridon)--a new calcium antagonist and derivative of 1,4-dihydopyridine]. Simkhovich BZ; Mezhapuke RIa; Dubur GIa Farmakol Toksikol; 1988; 51(3):30-4. PubMed ID: 2842181 [TBL] [Abstract][Full Text] [Related]
36. No effect of nifedipine on atherogenesis in cholesterol-fed rabbits. Stender S; Stender I; Nordestgaard B; Kjeldsen K Arteriosclerosis; 1984; 4(4):389-94. PubMed ID: 6466196 [TBL] [Abstract][Full Text] [Related]
37. Vascular injury: mechanisms and manifestations. Nayler WG Am J Med; 1991 Apr; 90(4B):8S-13S. PubMed ID: 1826808 [TBL] [Abstract][Full Text] [Related]
38. Protective effect of nilvadipine against glutamate neurotoxicity in purified retinal ganglion cells. Otori Y; Kusaka S; Kawasaki A; Morimura H; Miki A; Tano Y Brain Res; 2003 Jan; 961(2):213-9. PubMed ID: 12531488 [TBL] [Abstract][Full Text] [Related]
39. The effect of nilvadipine, a dihydropyridine type calcium channel blocker, on local cerebral blood flow in rats. Furuichi Y; Takakura S; Satoh H; Mori J; Kohsaka M Jpn J Pharmacol; 1992 Apr; 58(4):457-60. PubMed ID: 1405041 [TBL] [Abstract][Full Text] [Related]
40. Methylflavonolamine protects aorta from atherosclerosis in cholesterol-fed rabbits. Zhang MS; Zhou EF; Wang MZ; Li XM Zhongguo Yao Li Xue Bao; 1993 Mar; 14(2):133-6. PubMed ID: 8352005 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]